SGS Streamlines Clinical Trial Data Management with Veeva Vault EDC | News

Global CRO uses CDMS Veeva Vault to streamline study design and improve data quality

BARCELONASpain, June 8, 2022 / PRNewswire / – Veeva systems (NYSE: VEEV) announced today that SGS Health Science, a leading contract research organization (CRO), System Veeva Vault EDC was introduced to improve the collection and quality of on-site data and thus shorten the duration of research in clinical trials. The app is part of the CDMS Veeva Vault and gives SGS greater data control and greater flexibility in planning and conducting research. With Vault EDC, SGS can translate complex protocols into user-friendly case book designs and adapt to changes during the study with no downtime or migration.

Veeva systems

“SGS is continually developing its approach to data management to meet the challenges our biotech and pharmaceutical customers face in clinical research,” he said. Joris De Bondt, head of EDC at SGS Health Science. “With easy-to-use features that meet today’s complex research needs, Veeva Vault EDC allows us to better monitor and manage research using reliable real-time data from our sites.”

SGS provides global Phase I to IV clinical research services with a focus on early development and biometrics. The introduction of Vault EDC builds on SGS’s success in streamlining and automating research processes Veeva Vault CTMS and Veeva Vault eTMF. The use of connected applications on a single cloud platform enables better research monitoring, real-time data and document management, and faster research processes such as payments to research institutions. In the future, SGS plans to use Veeva RTSM to optimize data quality and research efficiency.

“We are proud to partner with SGS and support the company in its quest to increase the speed and efficiency of clinical trials,” he said. Paul MacDonald, Senior Strategy Director, CDMS Veeva Vault. “With the launch of Veeva Vault EDC, SGS will improve data monitoring and management in its large network of research facilities conducting clinical trials.

Additional information
For more information on Veeva Vault EDC, please visit
Connect with Veeva on LinkedIn:
Follow @veeva_eu on Twitter:

Information about SGS
SGS provides high-quality analytical testing and clinical research services to support drug discovery, registration, development and production. We use our network of laboratories, manufacturing plants and clinical research centers in North America, Europe, and Asia Pacific to support you every step of the way to deliver world-class, fully compliant biopharmaceutical and pharmaceutical drugs and medical devices.

Additional information
For more information on SGS CR, please visit
Connect with SGS on LinkedIn

About Veeva systems
Veeva is a leading provider of cloud-based software solutions to the global life sciences industry. Veeva is committed to innovation, superior product quality and customer success. The company serves over 1,000 clients, from the world’s largest pharmaceutical companies to start-ups of biotechnology companies. As a non-profit corporation, Veeva seeks to combine the interests of all stakeholders, including customers, employees, shareholders, and industries it serves. for more information visit

Forward-Looking Statements for Veeva
This press release contains forward-looking statements regarding Veeva’s products and services, and the expected results or benefits of using our products and services. Such statements are based on our current expectations. Actual results may differ materially from those presented in this version and we do not assume any obligation to update these statements. There are a number of risks that could adversely affect our performance, including the risks and uncertainties discussed on our 10-Q form for the period ended Saturday March 30. April 2022 are mentioned that you here (See pages 37 and 38 for a summary of risks that may affect our business) and our next SEC filing, available at can be seen.

Logo –

Selected Leveraged Products at Veeva Systems Inc (A)With knockouts, speculative investors can disproportionately participate in price movements. Just choose the leverage you want and we’ll show you the right products open to Veeva Systems Inc (A)

The leverage must be between 2 and 20

No data

Leave a Comment